Samuel Weglein

Managing Principal
Samuel Weglein



Ph.D., economics, Columbia University; B.A., economics, Yeshiva University

Summary of Experience

Dr. Weglein is an economist who testifies and supports testifying experts in complex antitrust and securities litigation, and in international arbitration. He testified recently on behalf of several large banks (market definition, competitive effects and damages) in an antitrust case involving municipal bond markets, and has testified on damages in a major arbitration case in the shipping industry. He recently co-led a team of consultants, working with counsel in the successful defense of three traders in the US v. Richard Usher, et al. criminal antitrust case in the foreign exchange market; he also co-lead a team of consultants working with the US Department of Justice (DOJ) in its successful efforts to block the Anthem/Cigna merger and has provided consulting services to DOJ in other mergers involving health care markets. He has worked in private litigation brought by health care providers against payors, several qui tam matters in health care markets, and various matters involving the health care provider and pharmaceutical markets. Dr. Weglein is the newsletter editor of the antitrust subcommittee of the ABA’s Litigation Section, as well as Analysis Group’s representative to the Board of the New York International Arbitration Council. He has made presentations to The Knowledge Group, Global Competition Review, the New York State Bar Association, the Moot Alumni Association, and the DOJ, and has coauthored numerous publications.

Selected Publishing